Mabpharm Limited

Mabpharm Limited stands as a leading biopharmaceutical company dedicated to the research and development of innovative drugs and biosimilars for cancer and autoimmune diseases. Mabpharm Limited is committed to bringing high-quality, affordable biologics to the market through an efficient R&D system and cost-effective pharmaceutical production capabilities. Mabpharm Limited aims to develop differentiated therapeutic products, fully leveraging extensive R&D experience.

Mabpharm Limited's drug candidate pipeline currently includes 11 monoclonal antibody drugs and one strong antibody drug, featuring three core products. Mabpharm's production site in Taizhou is equipped with advanced monoclonal antibody bioreactor systems, positioning it as one of the largest antibody drug production facilities in China in terms of production capacity. Mabpharm Limited's primary address is NO. 301 Libing Road, ZhangJiang Hi-Tech Park, Shanghai, 201300, CN.

Mabpharm Limited continually strives to improve and expand its reach. We invite the management team at Mabpharm Limited to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work and expansive capabilities.